Clinical and Immunological Long-term Follow-up of Patients With Pemphigus Included in the " RITUXIMAB 3 " Trial

Condition:   Autoimmune Diseases Interventions:   Drug: Rituximab;   Drug: corticosteroids'therapy Sponsor:   University Hospital, Rouen Not yet recruiting (Source: ClinicalTrials.gov)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.

from #Head and Neck by Sfakianakis via simeraentaxei on Inoreader http://bit.ly/2CjIr7m